PSYENCE BIOMEDICAL LTD. — Form SCHEDULE 13D/A
Filed October 15, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 12/100
What the filing says
Amendment to Schedule 13D filing identifying directors and executive officers of Psyence Labs Ltd. (the reporting person). Key personnel listed: Control Services Corp. as director; Ronel Anneli Williams and Kim Setzkorn as authorized signatories (both Mauritius citizens); Tony Budden as Chief Executive Officer (South Africa). No ownership percentages, share counts, or transaction amounts disclosed in this excerpt. Filing does not indicate material changes to beneficial ownership or control.
Why this rating
Routine amendment updating management roster; no transactions, stakes, or financial terms disclosed. Administrative filing.
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.